• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者血清蛋白的独特糖基化:简短通讯

Distinct glycosylation of serum proteins in patients with cancer: brief communication.

作者信息

Rostenberg I, Guízar-Vázquez J, Suárez P, Rico R, Nungaray L, Domínguez C

出版信息

J Natl Cancer Inst. 1978 Jan;60(1):83-7. doi: 10.1093/jnci/60.1.83.

DOI:10.1093/jnci/60.1.83
PMID:415148
Abstract

Concanavalin A and wheat germ agglutinin, lectins that interact with serum glycoprotein in a manner similar to the antigen--antibody reaction, were used as "antibodies" in a single radial immunodiffusion technique to test a coded serum panel (from the National Cancer Institute, Bethesda, Md., and the Mayo Clinic, Rochester, Minn.) containing a) 99 serum samples from patients with different types of malignant neoplasms of the gastrointestinal tract, prostate gland, and lung, b) 50 samples from patients with benign diseases of the same organs as those affected in the cancer patients, and c) 50 samples from apparently healthy smokers. The resulting precipitation rings were not correlated to serum protein concentration, and the differences (demonstrated by Student's t-test and with a generalization of the one-sided two-sample Kolmogorov-Smirnov statistic for evaluating diagnostic tests) established that serum glycoproteins are glycosylated differently in cancer patients than in people without cancer.

摘要

伴刀豆球蛋白A和麦胚凝集素,这两种凝集素以类似于抗原 - 抗体反应的方式与血清糖蛋白相互作用,在单向免疫扩散技术中用作“抗体”,以检测一组编码血清样本(来自马里兰州贝塞斯达的国家癌症研究所和明尼苏达州罗切斯特的梅奥诊所),其中包括:a)99份来自患有胃肠道、前列腺和肺部不同类型恶性肿瘤患者的血清样本,b)50份来自与癌症患者受影响器官相同的良性疾病患者的样本,以及c)50份来自明显健康的吸烟者的样本。所得沉淀环与血清蛋白浓度无关,并且差异(通过学生t检验以及用于评估诊断测试的单侧双样本柯尔莫哥洛夫 - 斯米尔诺夫统计量的推广来证明)表明癌症患者血清糖蛋白的糖基化与无癌症人群不同。

相似文献

1
Distinct glycosylation of serum proteins in patients with cancer: brief communication.癌症患者血清蛋白的独特糖基化:简短通讯
J Natl Cancer Inst. 1978 Jan;60(1):83-7. doi: 10.1093/jnci/60.1.83.
2
Altered carbohydrate content of alpha1-antitrypsin in patients with cancer.癌症患者α1-抗胰蛋白酶的碳水化合物含量改变。
J Natl Cancer Inst. 1978 Oct;61(4):961-5.
3
Gc globulin and prealbumin serum levels in patients with cancer and benign inflammatory diseases and in asymptomatic smokers.癌症患者、良性炎症性疾病患者及无症状吸烟者的Gc球蛋白和前白蛋白血清水平
J Natl Cancer Inst. 1979 Feb;62(2):299-300.
4
N-glycosylation of serum proteins in disease and its investigation using lectins.疾病中血清蛋白的N-糖基化及其凝集素研究
Clin Chim Acta. 1992 Jun 30;208(3):149-71. doi: 10.1016/0009-8981(92)90073-y.
5
Analysis of the N-glycosylation of the serum glycoproteins defined by Con A, PHA-E, RCA1 and WGA in Chinese patients with gastrointestinal diseases.对中国胃肠道疾病患者中由刀豆球蛋白A、红细胞凝集素E、蓖麻凝集素1和麦胚凝集素所定义的血清糖蛋白的N-糖基化分析。
Chin Med Sci J. 1996 Mar;11(1):36-40.
6
[Immunochemical investigations on serum proteins of tumor patients (author's transl)].
Med Klin. 1974 Aug 30;69(35):1399-1401.
7
[Clinical evaluation of a serum immunosuppressive (IS) substance in various diseases].
Gan To Kagaku Ryoho. 1982 Dec;9(12):2104-12.
8
A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.利用新开发的糖蛋白质组学技术发现血清中癌症糖生物标志物的策略。
FEBS J. 2010 Jan;277(1):95-105. doi: 10.1111/j.1742-4658.2009.07430.x. Epub 2009 Nov 17.
9
Clinical significance of fucose level in glycoprotein fraction of serum in patients with malignant tumors.
Cancer Res. 1977 Nov;37(11):4101-3.
10
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.血清YKL-40水平和壳三糖苷酶活性作为原发性前列腺癌和良性前列腺增生的潜在生物标志物。
Urol Oncol. 2008 Jan-Feb;26(1):47-52. doi: 10.1016/j.urolonc.2007.07.020.

引用本文的文献

1
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.基于糖基转移酶基因的标志物为预测卵巢癌的预后和免疫治疗反应提供了一种很有前途的工具。
J Ovarian Res. 2023 Jan 7;16(1):5. doi: 10.1186/s13048-022-01088-9.
2
Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion.调控 TRAIL 受体诱导的细胞死亡在膜水平:一场致命的讨论。
Recent Pat Anticancer Drug Discov. 2011 Sep;6(3):311-23. doi: 10.2174/157489211796957757.
3
[Glycoproteins: their biological and clinical significance. II (author's transl)].
[糖蛋白:它们的生物学和临床意义。II(作者译)]
Klin Wochenschr. 1979 Mar 1;57(5):199-214. doi: 10.1007/BF01477489.